Eight different types of ubiquitin linkages are present in eukaryotic cells that regulate diverse biological processes. Proteins that mediate specific assembly and disassembly of atypical Lys6, Lys27, Lys29 and Lys33 linkages are mainly unknown. We here reveal how the human ovarian tumor (OTU) domain deubiquitinase (DUB) TRABID specifically hydrolyzes both Lys29-and Lys33-linked diubiquitin. A crystal structure of the extended catalytic domain reveals an unpredicted ankyrin repeat domain that precedes an A20-like catalytic core. NMR analysis identifies the ankyrin domain as a new ubiquitin-binding fold, which we have termed AnkUBD, and DUB assays in vitro and in vivo show that this domain is crucial for TRABID efficiency and linkage specificity. Our data are consistent with AnkUBD functioning as an enzymatic S1′ ubiquitin-binding site, which orients a ubiquitin chain so that Lys29 and Lys33 linkages are cleaved preferentially.
a r t i c l e s Protein ubiquitination is a versatile post-translational modification that regulates an increasingly large number of cellular processes. This versatility originates from the ability of ubiquitin to form eight structurally and functionally distinct polymers, in which ubiquitin molecules are linked through one of seven lysine residues or through the N terminus 1, 2 . It is clear from proteomic analysis that all ubiquitin linkages exist in eukaryotic cells 3 , however the functions of the so-called atypical ubiquitin chain types linked through Lys6, Lys11, Lys27, Lys29 or Lys33 remain obscure. Recent proteomics data show that Lys29 linkages may be the third most common chain type in mammalian cells, accounting for ~10% of all linkages 4 . It has been suggested that several HECT E3 ligases mediate the Lys29 linkage assembly in vivo [5] [6] [7] , and among the reported cellular substrates of Lys29 ubiquitination are signaling molecules, including microtubule affinity-regulating kinases (MARKs) 8 , Deltex 7 and β-catenin 6 . In Saccharomyces cerevisiae, the ubiquitin fusion degradation (UFD) pathway involves Lys29 linkages 9, 10 .
Atypical ubiquitin chains have only recently become available as in vitro reagents through chemical biological methods. Ubiquitin lysine residues are exchanged genetically or by peptide synthesis for those lysine derivatives that can be chemically ubiquitinated, either through protection, specific deprotection and activated ligation (GOPAL method) 11 or, when a thiolysine derivative is incorporated, by direct ubiquitination using native chemical ligation protocols [12] [13] [14] . Both strategies allow generation of isopeptide-linked diubiquitin molecules with atypical linkages and enable comprehensive analysis of linkage specificity in DUBs.
Human cells include ~90 DUBs that can be subclassified into five families 15, 16 . Among these, ubiquitin-specific proteases (USPs) show little linkage specificity 11, 17 , whereas the JAMM metalloproteases contain Lys63-specific members 18, 19 . In humans, the OTU family includes 14 enzymes with distinct specificity profiles, including Lys11-and Lys48-specific members 20, 21 . Ovarian tumor family DUBs contain a papain-like catalytic core of ~180 amino acids (aa) 15 . The molecular basis for the linkage specificity in OTU domains is unclear, and structural information is available only for OTUB1 (ref. 20) , OTUB2 (ref. 22) and A20 (refs. 23,24) in the absence of ubiquitin, and for yeast Otu1 and a viral OTU in complex with a ubiquitin suicide inhibitor [25] [26] [27] [28] . In addition to their catalytic domain, many OTU members have additional ubiquitin-binding domains (UBDs) 15 . At least 20 different UBD families have been described, and knowledge of linkage-specific UBDs have provided the means to understand the roles of different ubiquitin linkages in cells 29 .
A20 is the best-studied OTU-family DUB, and it serves an important function as a negative-feedback regulator in nuclear factor-κB (NF-κB) signaling 30 . Other OTU enzymes have roles in interferon signaling 31, 32 and in p97 (cdc48)-mediated processes 33, 34 , but the cellular functions of most OTU enzymes remain to be discovered.
The OTU family member TRABID (ZRANB1) has been linked to Wnt-β-catenin signaling, as a positive regulator of β-catenin-mediated transcription 35 . TRABID includes a catalytic domain closely related to that of A20 (refs. 22,23,36) . Recently, we further showed that the TRABID OTU domain hydrolyzes Lys29-linked diubiquitin with 40-fold higher efficiency compared to Lys63-linked diubiquitin, whereas linear chains, or Lys6-, Lys11-and Lys48-linked diubiquitin, are not cleaved, identifying TRABID as the first Lys29-specific OTU domain enzyme 11 . This implicates atypical chains in Wnt-β-catenin signaling, although the molecular steps in the signaling cascade have a r t i c l e s not yet been identified. Also, TRABID activity toward Lys27 and Lys33 linkages has not yet been tested, as these chain linkages have not been available.
Here, we set out to determine how TRABID DUB activity and specificity are achieved. We tested the DUB activity of TRABID against the complete panel of eight different ubiquitin linkages, and we showed that it cleaves Lys29 and Lys33 linkages with marked preference over Lys63 linkages but cleaves no other chain type. Our crystal structure of the N-terminally extended TRABID OTU domain reveals a catalytic fold similar to that of A20, which is extended by two ankyrin repeats positioned such that they can form a proximal ubiquitin-binding site. Indeed, the isolated ankyrin domain binds to ubiquitin, and NMR experiments map the interaction interfaces to a conserved hydrophobic surface of the ankyrin module and to the hydrophobic Ile44 patch of ubiquitin. We provide evidence that the ankyrin-repeat ubiquitin-binding domain contributes to enzymatic efficiency and linkage specificity in vitro and in vivo.
RESULTS

Specificity of the extended OTU domain of TRABID
The human TRABID protein spans 708 aa and contains three N-terminal Npl4-like zinc-finger (NZF) domains (residues 1-200), and a C-terminal OTU domain (residues 340-700) ( Fig. 1a) . The C-terminal OTU domain of TRABID is closely related to the previously characterized OTU domain of A20 (refs. 23,36) . However, a stretch of ~100 highly conserved residues upstream of the TRABID OTU domain (residues 245-340; see below) indicate an extension of the catalytic fold not present in A20.
We tested the extended fragment of the TRABID OTU domain (residues 245-697) against the complete panel of eight differently linked diubiquitin molecules. In this qualitative analysis, we defined DUB specificity as the enzymatic concentration at which the preferred linkage type was cleaved completely at a defined time point. TRABID cleaved Lys29-and Lys33-linked diubiquitin with higher activity compared to Lys63-linkages ( Fig. 1b) , consistent with previous quantitative data 11 . The remaining diubiquitin molecules linked through Lys6, Lys11, Lys27 or Lys48, or linear diubiquitin, were not cleaved ( Fig. 1b) . Hence, TRABID has a dual specificity against two atypical ubiquitin chains linked through Lys29 and Lys33, in marked preference over Lys63 linkages.
Crystal structure of the extended OTU domain
To understand the molecular basis for the unique DUB specificity of TRABID, we purified the extended OTU domain to homogeneity and crystallized it. Needle crystals diffracted to 2.23 Å on the ID23-2 beamline at the European Synchrotron Radiation Facility (ESRF). We obtained phase information from a SIRAS experiment using crystals derivatized with gold cyanide (AuCN). The resulting Figure 1 Structure and specificity of an extended TRABID OTU domain. (a) Schematic representation of the functional domains of TRABID (top) and species conservation derived from a multiple sequence alignment (http://www.ensembl.org) (middle). An extended catalytic OTU domain was analyzed (residues 245-697, bottom). (b) Linkage specificity of the extended catalytic OTU domain of TRABID using diubiquitin molecules of all eight linkage types, analyzed as reported before 26 . TRABID was incubated with diubiquitin for the indicated times, and the reaction mixtures were resolved on an SDS-PAGE gel and silver stained. Ub, ubiquitin. (c) Structure of the extended TRABID OTU domain. The catalytic core is colored in shades of blue, where dark blue indicates the minimal OTU core domain, and the lighter blue indicates additional secondary structure elements found in the A20-like subfamily of OTU DUBs. The ankyrin repeats are shown in two shades of orange. The catalytic triad residues are indicated in ball-and-stick representation. (d) Structure of A20 (green, left, PDB 2VFJ 23 ) and superposition with TRABID (blue, right). (e) Catalytic triad residues of TRABID are shown in ball-and-stick representation with yellow sulfur, red oxygen and blue nitrogen atoms. A red sphere indicates a water molecule, and yellow dotted lines indicate hydrogen bonds. A 2F o -F c electron density map contoured at 1σ covers relevant residues. (f) The A20 catalytic triad is shown, with atoms colored as in e. a r t i c l e s electron density maps were of high quality ( Supplementary Fig. 1a ), and the structure was built and refined (final statistics are shown in Table 1 ).
The crystallized fragment of TRABID ( Fig. 1c) contains an OTU domain (residues 339-693) with a characteristic triangular shape similar to that of A20 ( Fig. 1c,d) 23, 24 that is preceded by an α-helical domain of 96 aa (see below). The two independent domains are connected by the last helix of the helical domain (αB2) projecting away from the OTU fold ( Fig. 1c) . The existence of a flexible linker between the domains and the lack of notable additional interactions at the small interface (313 Å 2 ) indicate potential conformational freedom of the α-helical domain with respect to the OTU domain.
The OTU domain folds of TRABID and A20 superpose well (r.m.s. deviation of 1.5 Å over 275 aa), and all secondary structure elements are conserved ( Fig. 1c,d and Supplementary Fig. 1b ). The catalytic Cys443 and His585 of TRABID superpose well with the A20 catalytic center ( Fig. 1e,f ).
Two ankyrin repeats extend the catalytic domain
Fold analysis of the adjoining α-helical domain (residues 245-340), using Dali 37 , revealed the presence of two ankyrin repeats ( Fig. 2a) . Ankyrin repeats include ~30 aa and consist of two interacting helices connected by short loops. Multiple repeats 'stack' through a conserved ankyrin motif, forming arc-shaped structures 38 (Fig. 2b) . In TRABID, the first ankyrin repeat spans residues 260-290 and is connected to the second repeat (residues 313-340) by a long linker that packs against what would correspond to the concave surface in an extended ankyrin-repeat structure ( Fig. 2c) . However, a conserved N-terminal helix (αA0, residues 245-259) that packs against the first ankyrin repeat, and the C-terminal OTU domain that directly extends from the second repeat, define the boundaries for the two ankyrin repeats in TRABID (Fig. 1c) . The primary sequence of these terminal repeats is divergent from the easily identifiable ankyrin motif in internal repeats, explaining why the ankyrin domain of TRABID had not been annotated.
Ubiquitin-binding sites in TRABID
OTU domain enzymes contain a high-affinity S1 ubiquitin-binding site that binds ubiquitin (termed the 'distal' ubiquitin in a diubiquitin) and positions its C terminus toward the active site independently of the linkage type 15 . Ovarian tumor-domain complex structures with ubiquitin bound at the S1 site have been reported for yeast Otu1 (yOtu1, Fig. 2d ) 25 and for a viral OTU domain (vOTU, Supplementary  Fig. 1c ) [26] [27] [28] . Both OTU domains contain only ~180 aa and define the minimal OTU domain core conserved in TRABID (Figs. 1c and 2d,e). TRABID superposes on yeast Otu1 with an r.m.s. deviation of 2.0 Å over 99 aa ( Fig. 2e ) and superposes on viral OTU with an r.m.s. deviation of 2.5 Å over 105 aa (Supplementary Fig. 1c ).
The structures of the complex indicate the position of the distal ubiquitin bound to the S1 site of the enzyme ( Fig. 2e) . All residues interacting with the C-terminal tail of the distal ubiquitin are conserved among OTU domains, indicating identical binding modes at the catalytic center itself. However, ubiquitin binds to yeast Otu1 and viral OTU in different orientations, and it interacts with distinct OTU surfaces in the two structures 26 . Compared to yeast Otu1 and (green) with ubiquitin (yellow) bound at the S1 site (PDB 3BY4 (ref. 25) ). The orientation matches that of the minimal OTU domain core indicated in Figure 1c . Ub, ubiquitin. (e) Superposition of TRABID and yeast Otu1 reveals the relative position of the S1 ubiquitin-binding site on TRABID, and this suggests that the ankyrin domain may constitute an S1′ ubiquitin-binding site.
a r t i c l e s viral OTU, TRABID contains additional secondary structure elements that would require the distal ubiquitin to rotate and/or shift in order to bind the S1 site ( Fig. 2e) . Hence, although the position of the S1 ubiquitin-binding site can be confidently assigned, the orientation of the S1 ubiquitin is difficult to predict without knowing the structure of the complex. By contrast, the existence or location of an S1′ ubiquitin-binding site (coordinating the 'proximal' ubiquitin in diubiquitin, which provides the lysine residue to the isopeptide bond) is not known for any OTU domain. We find it interesting that in TRABID, the adjacent ankyrin module preceding the OTU fold is located such that it could serve as an S1′ ubiquitin-binding site ( Fig. 2e) . Ankyrin-repeat domains mediate protein interactions through a variety of surfaces 38 , but ubiquitin has not been reported to bind ankyrin repeats.
TRABID ankyrin domain mediates ubiquitin interactions
To understand whether the ankyrin domain interacts with ubiquitin, and how, we conducted NMR studies using a 13 C, 15 N-labeled ankyrin domain. We obtained full sequence-specific backbone resonance assignments from triple resonance experiments ( Fig. 3a and Supplementary Fig. 2a ). The addition of 250-µM unlabeled ubiquitin resulted in marked perturbations of a subset of ankyrin domain resonances in 1 H-15 N HSQC spectra. A further increase of ubiquitin concentration (1 mM) allowed us to unambiguously assign the perturbed resonances ( Fig. 3b and Supplementary Fig. 2a ). This confirmed that the ankyrin domain of TRABID interacts with ubiquitin. To our knowledge, this is the first description of an ankyrin repeat as a ubiquitin-binding fold, which we refer to as the ankyrin ubiquitinbinding domain, or AnkUBD. Supplementary Fig. 2b ) are shown in red on a white AnkUBD surface.
a r t i c l e s
The resulting chemical shift map shows that the entire second ankyrin repeat (residues 313-340) and an additional small loop (residues 291-295) experienced strong perturbations upon addition of ubiquitin (Fig. 3c) . The four residues that had the strongest perturbation-Ala292, His317, Ile320 and Leu332-form a hydrophobic patch on the AnkUBD (Fig. 3d,e ). Furthermore, Thr314 and Leu332 showed exchange broadening upon addition of ubiquitin, indicating that they may also be involved in ubiquitin interactions (Supplementary Fig. 2a) .
The AnkUBD extension of the TRABID OTU domain is an evolutionarily conserved feature. A sequence alignment derived from all TRABID sequences annotated in the Ensembl database (http://www.ensembl.org/) reveals that the ubiquitin-interacting residues on the AnkUBD are evolutionarily invariant among TRABID orthologs, indicating their functional importance ( Fig. 3f and Supplementary Fig. 2b ).
Ankyrin UBD interacts with ubiquitin hydrophobic patch
We next confirmed the interaction of the isolated AnkUBD with 15 N-labeled ubiquitin using chemical shift analysis of 1 H-15 N HSQC spectra. Ubiquitin resonances that were perturbed upon addition of increasing AnkUBD concentrations (from 100 to 535 µM, Fig. 4a ) were found in three regions of ubiquitin, surrounding Leu8, Ile44 and Val70, which constitute the most common ubiquitin-binding site for protein interactions, the Ile44 hydrophobic patch ( Fig. 4b-d ). NMR-based affinity measurements indicated a dissociation constant K d of 134 ± 19 µM for the AnkUBD-ubiquitin interaction (Fig. 4a) , which is comparable to other UBDubiquitin interactions 29 . Hence, the hydrophobic surface of the AnkUBD interacts with the hydrophobic Ile44 patch of ubiquitin.
To investigate the interaction between AnkUBD and ubiquitin further, three AnkUBD mutants (H317A, I320D and L332E) were analyzed for their ability to interact with 15 N-labeled ubiquitin. The correct folding of all mutants was confirmed by NMR and circular dichroism spectroscopy (data not shown). We observed no chemical shift perturbation in 15 N-labeled ubiquitin with AnkUBD L332E, and we detected fewer and greatly attenuated shift perturbations with H317A and I320D AnkUBD mutants, indicating some residual ubiquitin binding ( Fig. 4e and Supplementary Fig. 3 ). K d measurements confirmed this and indicated an affinity that was at least ten times weaker (>1,200 µM) for the AnkUBD H317A mutant than for the others (no K d values could be determined for the I320D or L332E mutants). Our mutagenesis analysis therefore confirms the presence of a single ubiquitinbinding surface on the AnkUBD of TRABID.
Ankyrin UBD contributes to linkage-specificity of TRABID
The presence of the AnkUBD as a ubiquitin-binding fold in close proximity to the catalytic site suggests that it may serve as an enzymatic S1′ ubiquitin-binding site, directly affecting TRABID's DUB efficiency. Moreover, the S1′ site may affect TRABID specificity, as it may preferentially present a subset of ubiquitin lysine residues to the catalytic site. Figure 4 AnkUBD binds the ubiquitin hydrophobic patch. Ubiquitin (Ub) binding to the AnkUBD was confirmed by NMR shift mapping experiments, for which spectra of 15 N ubiquitin were recorded in the absence and presence of AnkUBD ( Supplementary Fig. 3 ).
(a) Perturbation of a selected resonance (that of ubiquitin Leu43, yellow) by titration of increasing concentrations of AnkUBD (colored from red to cyan) is shown as an example. The complete spectra can be found in Supplementary Figure 3 . Supplementary Fig. 3 ).
a r t i c l e s Indeed, the crystallized fragment that included the AnkUBD and the AnkOTU domain showed higher DUB activity compared to the isolated OTU domain (residues 339-697), which was less active at similar concentration (Supplementary Fig. 4a) . The concentration of the isolated OTU domain was thus increased by six-fold to allow us to detect enzymatic activity (Fig. 5a) . The OTU fragment hydrolyzed Lys29, Lys33 and Lys63 with similar efficiency and also hydrolyzed Lys48 linkages. In addition, Lys6-and Lys11-linked diubiquitin was also cleaved but with low efficiency (Fig. 5a) . This contrasted with the AnkOTU fragment, which cleaved Lys29-linked and Lys33-linked ubiquitin and-less efficiently-Lys63-linked diubiquitin (Fig. 5a) . a r t i c l e s This result was reflected in a second analysis, in which TRABID variants were purified by using an N-terminal 3× Flag-tag from HEK293 cells and used in endpoint DUB assays. Full-length TRABID, similarly to AnkOTU, only cleaved Lys29-, Lys33-and Lys63-linked diubiquitin when left overnight for 16 h, whereas an OTU construct was more promiscuous, cleaving Lys48linked diubiquitin (as well as weakly cleaving Lys6 and Lys11 linkages) (Fig. 5b) . We confirmed the specificity of HEK293expressed TRABID variants for Lys29 and Lys33 linkages by timecourse analysis, in which these linkages were cleaved within 60 min by full-length and AnkOTU TRABID, whereas Lys63-linked diubiquitin was not cleaved during the first hour but only after incubation overnight for 16 h (Fig. 5c, panels 1 and 3 from the top). Although this was not a quantitative analysis, there was slightly higher activity of TRABID against Lys29 linkages compared to Lys33 linkages in our qualitative time-course assays (Fig. 5a,c) . Together, these data show that the AnkUBD restricts activity of the OTU domain, which cleaves (at least) four linkage types, to make TRABID most efficient for hydrolyzing Lys29 and Lys33 linkages.
Removal of the AnkUBD from either construct (that is, from full-length ∆Ank (FL ∆Ank) or OTU) also resulted in a less active protein that lacked noticeable activity in the first 60 min (Fig. 5c , panels 2 and 4 from the top), confirming the role of the AnkUBD in TRABID efficiency.
We next analyzed HEK293-expressed TRABID variants with point mutations in the AnkUBD that affect ubiquitin binding (Fig. 3) . Mutation of H317A, L332E and I320D in the AnkUBD reduced TRABID activity against diubiquitin substrates, either in the context of the full-length protein (Fig. 5d ) or in context of bacterially produced AnkOTU (Supplementary Fig. 4b) . The observed reduced activity of TRABID point mutants (in particular H317A and L332E) was similar to that resulting from removal of the AnkUBD from either construct.
Although Lys29 and Lys33 linkages are available only as diubiquitin, Lys63-linked ubiquitin chains are available as longer polymers, so we next studied the activity of TRABID variants against Lys63-linked hexaubiquitin (Fig. 5e) . Full-length TRABID cleaved hexaubiquitin efficiently, hydrolyzing most input material within 60 min. Consistent with our diubiquitin assays, removal or mutation of the AnkUBD decreased activity against K63-linked hexaubiquitin (Fig. 5e) , suggesting that the AnkUBD is also essential for hydrolysis of longer polyubiquitin chains.
NZF domains contribute to hydrolysis of longer ubiquitin chains TRABID contains three N-terminal NZF domains, which may also affect TRABID activity and specificity. A TRABID variant with mutations in all three NZF domains (changing the Thr-Tyr motif to Leu-Val 35 for the full-length NZF mutant (FL NZFmut)) was as active against diubiquitin as full-length TRABID or AnkOTU (Fig. 6a) . However full-length NZFmut TRABID was less active than full-length TRABID, when longer Lys63 chains were used as a substrate (Fig. 6b) , suggesting that the NZF domains contribute to cleaving longer ubiquitin chains by providing additional binding sites. The combined S1-S1′ site in TRABID may constitute the highest affinity diubiquitin-binding module (Fig. 6c) , otherwise the NZF domains would compete for binding to the hydrophobic patches in diubiquitin and render TRABID less active toward diubiquitin substrates, which was not the case (Fig. 5c) . The NZF domains, however, provide increased affinity for longer TRABID substrates that can bind simultaneously to AnkOTU and NZF domains (Fig. 6d) .
Overall, our in vitro analysis showed that (i) the TRABID OTU domain cleaves four out of eight linkage types, (ii) addition of the AnkUBD increases activity of TRABID for Lys29 and Lys33 linkages, effectively making it specific for these linkages (Fig. 6c) and (iii) the N-terminal NZF domain does not affect TRABID specificity against diubiquitin but may increase the efficiency of the enzyme against longer polymers (Fig. 6d) . This confirms the importance of the AnkUBD as a crucial determinant of TRABID DUB efficiency and specificity in vitro.
Inactive TRABID forms puncta enriched in atypical polyubiquitin
We next set out to provide evidence for the mechanistic models shown in Figure 6 in a physiological setting, for which we had to establish DUB assays in vivo. It has been reported that hemagglutinin (HA)-tagged, catalytically inactive, full-length TRABID C443S (that is, mutation of the catalytic Cys443 to serine) forms distinct cytoplasmic puncta upon overexpression in various human cell lines, whereas wild-type (WT) TRABID is distributed diffusely throughout the cytoplasm and nucleus 35 . An equivalent localization was observed with green fluorescent protein (GFP)-tagged TRABID, for full-length WT and full-length C443S (Fig. 7a,b) . We used the latter for fluorescence recovery after photobleaching (FRAP) experiments, revealing that the full-length C443S puncta are highly dynamic (that is, 50% of puncta fluorescence recovers within 30 s) and in rapid equilibrium exchange with the diffuse protein ( Fig. 7c) . Thus, inactive TRABID forms dynamic protein assemblies rather than stable a r t i c l e s aggregates. An equivalent catalytically inactive mutant of the closely related DUB Cezanne does not form puncta upon overexpression (Supplementary Fig. 5a ), suggesting that the propensity to form dynamic protein assemblies is not a general property of catalytically inactive OTU family proteins.
Ubiquitin binding through the N-terminal NZF domains of TRABID is crucial for puncta formation (because AnkOTU C443S or full-length NZFmut C443S do not form puncta 35 ; see Fig. 7d ), indicating that full-length C443S puncta contain ubiquitin. Indeed, coexpression of GFP-tagged full-length C443S with Flag-ubiquitin revealed that the full-length C443S puncta were positive for Flagubiquitin (Fig. 7e) . We then tested the panel of seven Flag-ubiquitin 'K-only' mutants (in which six out of seven lysine residues were mutated to arginine) for colocalization with TRABID puncta. We found that the full-length C443S puncta were positive for K29only, K33only, K27only and K63only ubiquitin mutants, whereas there was no detectable colocalization with K6only, K11only or K48only ubiquitin mutants ( Fig. 7e and Supplementary Fig. 6a ). This indicated that protein assemblies containing inactive TRABID have the defined set of atypical ubiquitin chains that TRABID preferentially hydrolyzes (with the exception of Lys27 linkages; see above).
All ubiquitin mutants were expressed at similar levels and did not form punctate patterns when transfected alone, either in the absence or presence of the proteasome inhibitor MG132 (Supplementary Fig. 5b) . Notably, the number or size of TRABID puncta was not affected when cells were pretreated with MG132 ( Supplementary  Fig. 5c ). It is possible that the puncta reflect TRABID self-assembly mediated by NZF domain binding to ubiquitin chains on TRABID itself. Coimmunoprecipitation of Flag-tagged TRABID C443S with HA-tagged ubiquitin after stringent washing under denaturing conditions revealed that TRABID is indeed ubiquitinated (data not shown). However, the puncta may also contain TRABID substrates bearing Lys29-, Lys33-and/or Lys63-linked ubiquitin chains.
In vivo deubiquitinase assay based on TRABID puncta
Given that atypical ubiquitin chains are enriched in TRABID puncta, we explored whether we could exploit these as substrates for in vivo DUB assays to validate the mechanistic models derived from our structural analysis (Fig. 7f-i and Supplementary Fig. 6b ). Coexpression of puncta forming GFP-tagged full-length C443S with full-length Flagtagged TRABID results in the disappearance of GFP puncta, instead producing a diffuse GFP fluorescence throughout the cell (Fig. 7g) ; the levels of GFP-tagged full-length C443S did not change under these conditions, as judged by western blot analysis (data not shown). By contrast, coexpression with full-length NZFmut (Fig. 7h) or with full-length C443S (data not shown) did not alter the punctate pattern. High expression of AnkOTU resulted in complete loss of puncta formation but moderate expression did not (Supplementary Fig. 6b ). Nuclei are stained using DAPI (middle). The merged image is shown to the right. (g-i) As in f, but in addition, Flag-tagged full-length WT TRABID constructs (g), full-length NZFmut (h) or full-length ∆Ank (i) were coexpressed (far left), and the presence of GFP puncta was assessed. Additional data are shown in Supplementary Figure 6b. a r t i c l e s Similarly, high overexpression of the TRABID OTU domain did not result in loss of TRABID puncta (Supplementary Fig. 6b) .
Notably, the punctate pattern was also unchanged upon coexpression of full-length ∆Ank TRABID, even after high levels of overexpression ( Fig. 7i) . This construct still contains functional NZF domains, and it localizes to full-length C443S puncta ( Supplementary  Fig. 5d ). This highlights the important functional role of the AnkUBD in TRABID activity and efficiency, which is essential to antagonize C443S puncta in vivo.
DISCUSSION
Availability of all ubiquitin chain types now allows a comprehensive linkage-specificity analysis of DUBs, and in the case of TRABID, reveals its dual specificity for Lys29-and Lys33-linked ubiquitin chains, two atypical ubiquitin chain types whose cellular roles are unclear. We achieved a molecular understanding of this unique specificity profile and identified a previously unknown UBD based on an ankyrin-repeat fold, which serves as a S1′ ubiquitin-binding site to position a subset of ubiquitin chains across the active site of the OTU domain.
The TRABID OTU domain is similar in sequence and structure to that of A20; however, both domains show distinct specificities. Whereas A20 preferentially cleaves Lys48 linkages (ref. 11; T.E.T.M. and D.K., unpublished data), the TRABID OTU domain cleaves Lys29, Lys33, Lys63 and Lys48 chains, but not the remaining chain types. Other OTU family members also have distinct specificity profiles 21, 26 . This indicates that OTU domain folds have intrinsic specificity; however, the molecular basis for this is currently unknown. Linkage specificity in DUBs is so far only understood for the Lys63-specific JAMM-family DUB AMSH-LP, which forms specific interactions with Lys63-flanking sequences 39 . However, the sequences flanking Lys29, Lys33, Lys48 and Lys63 are different 15 , so this is not likely to explain TRABID OTU domain specificity.
A previously unknown ubiquitin-binding fold, the AnkUBD, further restricts the linkage specificity of the TRABID OTU domain and makes TRABID most efficient for hydrolyzing Lys29 and Lys33 linkages. Our data are consistent with the AnkUBD serving as an enzymatic S1′ site that positions proximal ubiquitin moieties such that Lys29 and Lys33 are juxtaposed to the catalytic triad (Fig. 6c) . The AnkUBD binds directly to Lys48 of the proximal ubiquitin, suggesting that a Lys48-linked chain cannot use the AnkUBD. This is consistent with our in vitro data showing that residual Lys48 cleavage is independent of the AnkUBD. Therefore, the AnkUBD adjacent to the catalytic domain explains TRABID's DUB specificity profile.
It is not clear how the AnkUBD orients a proximal ubiquitin toward the active site. Docking of ubiquitin onto the AnkUBD using HADDOCK 40 indicated several potential binding modes (data not shown); however, all models indicated that the AnkUBD has to shift and rotate for any diubiquitin to bind across the active site. The flexible linker between the AnkUBD and the OTU domain probably permits this required plasticity, but future crystallographic studies of TRABID-diubiquitin complexes will be required to confirm this.
Almost 20,000 ankyrin repeats have been annotated in >3,500 human proteins, making this domain one of the most common protein folds 38 . Ankyrin repeats serve as protein binding modules, and our work adds ubiquitin to the list of ankyrin-interacting proteins. Ubiquitin binding by the AnkUBD is mediated by both helices of the C-terminal ankyrin repeat, through a hydrophobic surface that is mediated by residues that are conserved among ankyrin repeats.
Indeed, these residues are reminiscent of the TPLH motif that is characteristic of internal ankyrin repeats 41 , and it is possible that other ankyrin repeat-containing proteins may bind ubiquitin similarly to TRABID. However, terminal ankyrin repeats suited to bind ubiquitin are not easily identified by sequence analysis alone.
Although the AnkUBD is essential for TRABID efficiency and specificity, our analysis has also indicated a functional contribution of the NZF domains (Fig. 6) , but their relative position with respect to the catalytic site is unclear. A linker of ~50 nonconserved and flexible residues separates the NZF domains and the AnkUBD, and individual NZF domains are themselves connected by nonconserved, flexible linkers. Hence, the NZF module could provide additional ubiquitin-binding sites toward the distal (S2, S3, S4) or proximal (S2′, S3′, S4′) end (Fig. 6d shows the distal ubiquitin-binding sites). The number of ubiquitin-binding sites within the three NZF domains is also not clear, as they may consist of two ubiquitin-binding interfaces each 42, 43 . Alternatively, the NZF domains may target TRABID to its polyubiquitinated substrates, increasing DUB efficiency. This is suggested by our finding that the NZF domains are essential for recognition of TRABID puncta (Supplementary Fig. 5d ).
Additional UBDs are found in many DUBs, and seven of the 14 human OTU DUBs contain known UBD folds 15 . A ubiquitininteracting motif (UIM) in the deubiquitinase DUBA was shown to be functionally important for its role in interferon signaling 31 , and the A20 ZnF domains bind ubiquitin molecules through several interfaces 44 . The USP enzyme USP5 (IsoT) contains three UBDs that constitute S1′, S2 and S3 sites respectively 45 . However, for most DUBs, it is not known whether their additional UBDs constitute enzymatic ubiquitin-binding sites (for example, S1′ or S2) or whether they serve as targeting domains. Our work highlights the potential of UBDs to contribute additional levels of linkage specificity to DUBs, and presumably also to other aspecific enzymes of the ubiquitin cascade, such as E2s and E3s.
Recent proteomic data in unstimulated HEK293 cells suggests a relatively high abundance of Lys63 and Lys29 linkages, whereas Lys33 linkages are less abundant 4 . Although the cellular functions for the atypical ubiquitin chain types cleaved by TRABID remain to be determined, others have suggested that β-catenin itself is modified by the HECT domain ligase EDD, using Lys29 linkages (Lys33 chains were not analyzed). However, whether this leads to β-catenin stabilization 6 or destabilization 46 is not clear. We think it will be interesting to identify the functionally relevant TRABID substrates within the Wnt pathway that carry ubiquitin chains linked through Lys29 or Lys33, and to determine their functional relevance in signal transduction. This may shed light on the cellular function of these unusual and rare atypical ubiquitin linkages.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
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Note: Supplementary information is available on the Nature Structural & Molecular Biology website. a r t i c l e s experiments and discussions. Crystallographic data were collected at the European Synchrotron Radiation Facility beamline ID23-2. J.D.F.L. was supported by an Association for International Cancer Research grant (no. 07-0040 to M.B.). D.K. is an European Molecular Biology Organization (EMBO) Young Investigator. This work was supported by the Medical Research Council (MC_US_A024_0059 to M.B., MC_US_A024_0056 to D.K., and MC_US_A024_0051 to J.W.C.).
ONLINE METhODS
Purification and structure determination of TRABID ankyrin OTU. TRABID AnkOTU was expressed as a GST-fusion protein in Escherichia coli and purified by affinity chromatography. After removal of the GST tag by PreScission protease, anion-exchange chromatography and gel filtration produced homogeneous protein that was crystallized at 3.5 mg ml −1 . AnkOTU crystals grew from 150 mM NaCl, 100 mM NaOAc, 5 mM MgCl 2 , 50 mM MES, pH 5.9. Crystals were soaked in mother liquor containing 27.5% (v/v) ethylene glycol before freezing in liquid nitrogen. To obtain phase information, crystals were soaked in 1 mM KAu(CN) 2 for 1 h before cryoprotection. Diffraction data of the AnkOTU crystals were collected at the ESRF beamline ID23-2 to 2.23 Å (native) and 3.0 Å resolution at the peak wavelength for gold. Phases were obtained by SIRAS, from an initial set of sites obtained with the SHELX/hkl2map suite 48 . Site refinement was carried out in SHARP 49 , and subsequent density modification resulted in a high-quality map, which was interpreted by WarpNTrace 50 and manually rebuilt in Coot 51 . Refinement was carried out using PHENIX 52 , including simulated annealing and TLS B-factor refinement, resulting in the final statistics reported in Table 1. NMR analysis. 13 C, 15 N-labeled TRABID AnkUBD (residues 245-339) was expressed from a pOPIN-K vector in Rosetta2 pLacI cells. A 100-ml culture grown in LB medium overnight for 16 h was pelleted and resuspended in modified K-MOPS minimal media 53 , without nitrogen and carbon sources, and this was used to inoculate three liters of modified K-MOPS media supplemented with 13 C glucose-15 N ammonium chloride. Protein expression was induced after 16 h at 30 °C with 0.4 mM IPTG, and cells were harvested after a further 4 h. The protein was purified as for crystallography (see above) and concentrated to 10 mg ml −1 . Unlabeled ubiquitin (from bovine red blood cells, Sigma-Aldrich) was reconstituted in 50 mM Tris, pH 7.6, at 5 mM. 15 Production of full-length TRABID from mammalian cells. Five-hundred nanograms of plasmid was transfected using Lipofectamine 2000 (Invitrogen) in each well of a 6-well plate containing HEK293 cells. Forty-eight hours after transfection, cells from the six wells were combined and lysed in 1 ml of lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, complete protease inhibitor (Roche)), sonicated and centrifuged at 15,000g for 20 min. The entire
